- Report
- June 2021
- 149 Pages
Global
From €2503EUR$2,750USD£2,126GBP
€5006EUR$5,500USD£4,252GBP
- Report
- January 2023
- 118 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- August 2022
- 133 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2022
- 111 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2022
- 247 Pages
Global
From €4050EUR$4,450USD£3,440GBP
- Report
- November 2022
- 120 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2023
- 254 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- December 2022
- 105 Pages
Global
From €4546EUR$4,995USD£3,861GBP
- Report
- April 2025
- 96 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 71 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- April 2024
- 280 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP

The allograft market within the context of dermatology is a segment of the medical industry that focuses on the use of donor tissue to treat skin conditions. Allografts are typically used to treat burns, chronic wounds, and other skin conditions. The allografts are typically sourced from cadavers, and the tissue is processed and sterilized before being used in medical procedures. Allografts are often used in combination with other treatments, such as skin grafts, to provide the best possible outcome for the patient.
The allograft market is a growing segment of the medical industry, with more and more patients seeking out allograft treatments for their skin conditions. The use of allografts has been shown to reduce healing time and improve the overall outcome of the treatment.
Some companies in the allograft market include MiMedx, LifeNet Health, Organogenesis, and Osiris Therapeutics. Show Less Read more